USD 5.84
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 330.31 Million USD | 18.59% |
2022 | 278.53 Million USD | 2.81% |
2021 | 270.92 Million USD | -32.43% |
2020 | 400.96 Million USD | 58.3% |
2019 | 253.29 Million USD | 16.39% |
2018 | 217.63 Million USD | 6.22% |
2017 | 204.88 Million USD | 12.85% |
2016 | 181.54 Million USD | 220.81% |
2015 | 56.59 Million USD | 86.0% |
2014 | 30.42 Million USD | 281.95% |
2013 | 7.96 Million USD | 44.92% |
2012 | 5.49 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 317.5 Million USD | -3.88% |
2024 Q2 | 329.08 Million USD | 3.64% |
2023 Q1 | 273.19 Million USD | -1.92% |
2023 FY | 330.31 Million USD | 18.59% |
2023 Q3 | 275.91 Million USD | 0.42% |
2023 Q2 | 274.76 Million USD | 0.58% |
2023 Q4 | 330.31 Million USD | 19.71% |
2022 Q1 | 292.49 Million USD | 7.96% |
2022 Q2 | 293.93 Million USD | 0.49% |
2022 Q3 | 280.57 Million USD | -4.54% |
2022 Q4 | 278.53 Million USD | -0.73% |
2022 FY | 278.53 Million USD | 2.81% |
2021 Q2 | 241.16 Million USD | -41.1% |
2021 Q3 | 263.22 Million USD | 9.15% |
2021 Q4 | 270.92 Million USD | 2.93% |
2021 Q1 | 409.46 Million USD | 2.12% |
2021 FY | 270.92 Million USD | -32.43% |
2020 FY | 400.96 Million USD | 58.3% |
2020 Q3 | 398.66 Million USD | 5.26% |
2020 Q1 | 244.88 Million USD | -3.32% |
2020 Q4 | 400.96 Million USD | 0.58% |
2020 Q2 | 378.74 Million USD | 54.66% |
2019 FY | 253.29 Million USD | 16.39% |
2019 Q2 | 246.45 Million USD | 1.0% |
2019 Q3 | 249.64 Million USD | 1.29% |
2019 Q1 | 244.01 Million USD | 12.12% |
2019 Q4 | 253.29 Million USD | 1.46% |
2018 Q1 | 202.22 Million USD | -1.3% |
2018 Q3 | 206.74 Million USD | 1.2% |
2018 Q4 | 217.63 Million USD | 5.26% |
2018 FY | 217.63 Million USD | 6.22% |
2018 Q2 | 204.3 Million USD | 1.03% |
2017 Q2 | 179.98 Million USD | 2.65% |
2017 FY | 204.88 Million USD | 12.85% |
2017 Q4 | 204.88 Million USD | 5.78% |
2017 Q3 | 193.69 Million USD | 7.62% |
2017 Q1 | 175.33 Million USD | -3.42% |
2016 Q4 | 181.54 Million USD | 5.47% |
2016 Q1 | 45.67 Million USD | -19.3% |
2016 FY | 181.54 Million USD | 220.81% |
2016 Q2 | 165.91 Million USD | 263.28% |
2016 Q3 | 172.13 Million USD | 3.75% |
2015 Q1 | 33.1 Million USD | 8.8% |
2015 FY | 56.59 Million USD | 86.0% |
2015 Q2 | 35.8 Million USD | 8.15% |
2015 Q4 | 56.59 Million USD | 30.57% |
2015 Q3 | 43.34 Million USD | 21.07% |
2014 Q2 | 8.49 Million USD | 22.08% |
2014 Q1 | 6.95 Million USD | -12.68% |
2014 Q3 | 8.75 Million USD | 3.11% |
2014 Q4 | 30.42 Million USD | 247.49% |
2014 FY | 30.42 Million USD | 281.95% |
2013 FY | 7.96 Million USD | 44.92% |
2013 Q4 | 7.96 Million USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | 5.49 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 99.039% |
Allurion Technologies Inc. | 142.19 Million USD | -132.288% |
Artivion, Inc. | 510.61 Million USD | 35.311% |
Avanos Medical, Inc. | 456.1 Million USD | 27.579% |
Butterfly Network, Inc. | 84.22 Million USD | -292.196% |
Butterfly Network, Inc. | 84.22 Million USD | -292.196% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 90.716% |
Boston Scientific Corporation | 15.6 Billion USD | 97.883% |
CONMED Corporation | 1.46 Billion USD | 77.465% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 87.506% |
Paragon 28, Inc. | 162.95 Million USD | -102.697% |
Glaukos Corporation | 478.64 Million USD | 30.991% |
Globus Medical, Inc. | 1.08 Billion USD | 69.644% |
Inspire Medical Systems, Inc. | 104.29 Million USD | -216.702% |
Integer Holdings Corporation | 1.41 Billion USD | 76.627% |
Medtronic plc | 39.56 Billion USD | 99.165% |
Myomo, Inc. | 5.59 Million USD | -5806.619% |
Owlet, Inc. | 73.79 Million USD | -347.582% |
Penumbra, Inc. | 377.36 Million USD | 12.468% |
Vicarious Surgical Inc. | 21.89 Million USD | -1408.614% |
Smith & Nephew plc | 4.77 Billion USD | 93.075% |
STERIS plc | 4.74 Billion USD | 93.044% |
Stryker Corporation | 21.31 Billion USD | 98.451% |
Vapotherm, Inc. | 132.95 Million USD | -148.446% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 96.333% |